20 diciembre 2023

A Randomized, Controlled Trial Comparing Tearcare® and Cyclosporine Ophthalmic Emulsion for the Treatment of Dry Eye Disease ( SAHARA ) .


Si Nos Fijamos Solo en la I+D Para el Tratamiento del OJO SECO Hay Actualmente  1669  Ensayos Clínicos en Marcha :


Si Nos Fijamos en la I+D Para el Tratamiento de Ojo Seco en Personas con Syndrome de Sjogren ( Qué es la Indicación  en la Que va Dirigida TIVANISIRAN By Sylentis ) Hay Actualmente  254 Ensayos Clínicos en Marcha :






Treated With TearCare® Should Be a Preferred Treatment For Eye Disease ( DED )  Associated With MGD .


Prospective, Randomized, Masked, Controlled Trial To Evaluate The Safety And Effectiveness Of The TearCare® System In The Treatment Of The Signs And Symptoms Of Dry Eye Disease (SAHARA) .


TearCare®  Provides Statistically Superior And Sustained Improvement In TBUT And Múltiple Measures Of Meibomian Gland Secretion, And Non-Inferior Improvement In OSDI, Corneal And Conjuntival Staining, SANDE, EDS, And STS Versus CsA . ...